The system’s revenue increased to nearly $4.7 billion in 2014, up from $4.3 billion in 2013. Sentara’s expenses also grew last year, reaching $4.4 billion, up from about $4.1 billion the preceding year.
The system ended 2014 with net operating income of $272.4 million, which was an improvement over operating income of $221.8 million in 2013.
Sentara’s nonoperating gains fell from about $390 million in 2013 to $92.7 million last year, which had a negative effect on the system’s bottom line.
More articles on healthcare finance:
10 hospital CFOs in the headlines this week
13 recent hospital outlook and rating actions
MedPAC makes 3 ‘two-midnight’ rule recommendations
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
